A Pilot Study of BXCL701 in Patients With Pancreatic Cancer

Conditions:   Cancer of Pancreas;   Cancer of the Pancreas;   Neoplasms, Pancreatic;   Pancreas Cancer;   Pancreatic Cancer Intervention:   Drug: Talabostat Mesylate Sponsors:   BioXcel Therapeutics Inc;   IQVIA Biotech Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials